ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2026

Zinzino group revenue increased with a total of 20 %, compared with the previous year.

 

The revenue in January for Zinzino's sales markets increased by 20% and amounted to SEK 274.1 (229.2) million. Faun Pharma's external sales increased and amounted to SEK 7.1 (4.7) million. Overall, the Group increased revenues by 20 % to SEK 281.2 (233.9) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK	26-Jan	25-Jan	Change
The Nordics	27.3	25.9	5%
Central Europe	90.1	69.4	30%
East Europe	29.4	34.2	-14%
South & West Europe	46.6	44.1	6%
The Baltics	10.5	10.4	1%
North America	41.3	21.3	94%
South America	4.0	0.9	344%
Asia-Pacific	23.0	21.5	7%
Africa	1.9	1.5	27%
Zinzino	274.1	229.2	20%
Faun Pharma	7.1	4.7	51%
Zinzino Group	281.2	233.9	20%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge : marketing@zinzino.com
 

Certified Adviser: Tapper Partners AB